Previous studies found the interactions between CHES1 and HDAC1/2 in ERα + breast cancer [28, 38], so we hypothesized that non-histone CHES1 might undergo acetylation and the acetylation further affected its expression. Here, FOXN3 is linked to breast carcinoma.